Lipogems enrolled the first patient in a U.S. study focusing on MicroFat injections in knee osteoarthritis.
MicroFat injections will be compared with corticosteroid injections for treating pain and function of patients with moderate knee osteoarthritis, according to a Jan. 13 news release. Yogesh Mittal, MD, of The Orthopaedic Clinic in Tulsa, Okla. enrolled the study’s first patient.
Up to 20 sites will be involved in the study. Lipogems’ injections serve as an alternative to total knee replacement.
Orthopedic surgeons, like many specialists, play a number of roles both inside and outside of work, all while trying to…
The highest paid orthopedic surgeon in Austin, Texas, earns $911,700, according to Medscape’s salary reporter tool, which is much higher…
In February, E. Scott Paxton, MD, an orthopedic surgeon at East Providence, R.I.-based University Orthopedics, became the first surgeon in…